Search for Clinical Trial Results
Graves Ophthalmopathy - 25 Studies Found
Status | Study |
Terminated |
Study Name: Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment Condition: Graves Ophthalmopathy Date: 2013-06-28 Interventions:
|
Terminated |
Study Name: Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment Condition: Thyroid-Associated Ophthalmopathy Date: 2006-02-07 Interventions: Drug: Lanreotide (Autogel formulation). Duration of treatment - 3 injections, 1 every 28 days |
Recruiting |
Study Name: Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues Condition: Thyroid Associated Ophthalmopathies Date: 2014-05-21 Interventions: Drug: bimatoprost 0.03% The patients will receive a single daily drop of bimatoprost for six months. |
Recruiting |
Study Name: The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy Condition: Graves' Ophthalmopathy Date: 2010-01-25 Interventions:
|
Recruiting |
Study Name: The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy Condition: Graves' Ophthalmopathy Date: 2005-09-13 |